Peptidyl Acyloxymethyl Ketones as Activity-Based Probes for the Main Protease of SARS-CoV-2

03 June 2020, Version 1
This content is a preprint and has not undergone peer review at the time of posting.


The global pandemic caused by SARS-CoV-2 calls for a fast development of antiviral drugs
against this particular coronavirus. Chemical tools to facilitate inhibitor discovery as well as
detection of target engagement by hit or lead compounds from high throughput screens are
therefore in urgent need. We here report novel, selective activity-based probes that enable
detection of the SARS-CoV-2 main protease. The probes are based on acyloxymethyl ketone
reactive electrophiles combined with a peptide sequence including non-natural amino acids
that targets the non-primed site of the main protease substrate binding cleft. They are the first
activity-based probes for the main protease of coronaviruses and display target labeling within
in a human proteome without background. We expect that these reagents will be useful in the
drug development pipeline, not only for the current SARS-CoV-2, but also for other


SARS-CoV-2 main protease
activity-based probes

Supplementary materials

VandePlassche-Barniol SARS-CoV-2-ABPs-draft200601SuppInf


Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.